Penumbra, Inc. (PEN)

NYSE: PEN · Real-Time Price · USD

336.18

+1.19 (0.36%)

Mar 13, 2026, 4:00 PM EDT - Market closed

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015	Dec '14 Dec 31, 2014	Dec '13 Dec 31, 2013
United States Revenue	1.09B	902.07M
United States Revenue Growth	21.03%	19.14%
International Revenue	311.90M	292.55M
International Revenue Growth	6.62%	-2.93%
Revenue (Total)	1.40B	1.19B
Revenue (Total) Growth	17.50%	12.86%

Revenue Breakdown

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015	Dec '14 Dec 31, 2014	Dec '13 Dec 31, 2013
Thrombectomy Revenue	947.92M	815.48M
Thrombectomy Revenue Growth	16.24%	20.39%
Embolization and Access Revenue	455.75M	379.14M
Embolization and Access Revenue Growth	20.21%	-0.53%
Revenue (Total)	1.40B	1.19B
Revenue (Total) Growth	17.50%	12.86%

Updated Dec 31, 2025. Data Source: Fiscal.ai.